- This page was created by volunteers like you!
- Help us make it even better. To learn more about contributing to MEpedia, click here.
- Join the movement
- Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
- Congratulations!
- MEpedia has got over 30 million views as of August 2022!
Growth differentiation factor 15
 | This article is a stub. |
Growth Differentiation Factor 15 or GDF15 is a cytokine and circulating protein produced in the body in response to different stressors.[1][2] Circulating GDF15 levels are known to be highly elevated in mitochondrial disorders, which have early skeletal muscle fatigue as a key symptom.[2]
Severe ME/CFS is associated with increased levels of GDF15, a circulating biomarker of cellular stress that appears which stable over several months.
ME/CFS[edit | edit source]
Melvin et al. (2019) investigated where GDF15 could act as a potential biomarker of cellular stress in ME/CFS patients, finding that GDF15 levels were positively correlated with fatigue levels in ME/CFS patients.[2] The same study, which compared GDF15 levels in 50 patients with severe ME/CFS and 100 patients with mild/moderate ME/CFS, also found higher GDF15 levels in patients with severe ME/CFS than in patients with multiple sclerosis or healthy controls, but no higher levels in patients with mild/moderate ME/CFS.[2]
Learn more[edit | edit source]
See also[edit | edit source]
References[edit | edit source]
- ↑ Zoltani, Csaba K. (2014). "Cardiovascular toxicity biomarkers". In Gupta, Ramesh C. (ed.). Biomarkers in Toxicity. Boston: Academic Press. pp. 199–215. ISBN 978-0-12-404630-6.
- ↑ Jump up to: 2.0 2.1 2.2 2.3 Melvin, Audrey; Lacerda, Eliana; Dockrell, Hazel; O'Rahilly, Stephen; Nacul, Luis (November 27, 2019). "Circulating levels of GDF15 in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Journal of Translational Medicine. doi:10.17863/CAM.46401. ISSN 1479-5876. Retrieved December 1, 2019.
